American Well Corporation ( (AMWL) ) has released its Q1 earnings. Here is a breakdown of the information American Well Corporation presented to its investors.
American Well Corporation, known as Amwell, is a prominent player in the healthcare technology sector, offering a comprehensive SaaS-based platform that enhances patient access to convenient and effective care. The company partners with healthcare providers to deliver integrated solutions across the care continuum.
In its first-quarter earnings report for 2025, Amwell announced a strong performance, highlighting significant progress in strategic initiatives and financial metrics. The company, in collaboration with Leidos, advanced its solutions within the Military Health System and focused on improving revenue quality and cost alignment.
Key financial metrics for the quarter included a total revenue of $66.8 million, with subscription revenue reaching $32.2 million and Amwell Medical Group visit revenue at $26.6 million. The company reported a gross margin of 53% and a net loss of $18.4 million, a notable improvement from the previous quarter’s loss of $44.6 million. Adjusted EBITDA also showed improvement, reducing to a loss of $12.2 million from $22.8 million in the fourth quarter of 2024. Total visits amounted to 1.3 million.
Looking ahead, Amwell remains committed to achieving cash flow breakeven from operations by 2026. The company reiterated its 2025 revenue guidance of $250 to $260 million and expects AMG visits to be between 1.3 and 1.35 million. For the second quarter of 2025, revenue is projected to range from $62 to $67 million, with adjusted EBITDA expected to be between a loss of $12 million and $10 million.
Amwell’s management continues to focus on strategic growth and operational efficiency, aiming for meaningful margin expansion and enhanced financial performance in the coming years.